Skip to content

Neurocognitive Rehabilitation Program for Disease of Addiction

Designing a Neuro Cognitive Rehabilitation Package for Drug Addicted Patients (NECOREDA) and Studying is Efficiency: Randomized Clinical Trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT2015090123849N1
Enrollment
120
Registered
2015-11-27
Start date
2015-10-25
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Opiate Dependence. Mental and behavioural disorders due to use of opioids

Interventions

Intervention 1: Intervention: Intervention group receive neurocognitive rehabilitation with developed package during 2 months. Cognitive rehabilitation sessions are 32 one-hour group sessions that hol
Rehabilitation
Placebo
Intervention: Intervention group receive neurocognitive rehabilitation with developed package during 2 months. Cognitive rehabilitation sessions are 32 one-hour group sessions that hold 4 times a wee
Control : Control group receive placebo intervention that is painting during 2 months. Painting sessions are 32 one-hour group sessions that hold 4 times a week.

Sponsors

Cognitive Science and Technologies Council (CSTS)
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
20 Years to 40 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: age 20 -40 years old; ability to read and speak in Farsi; meet DSM-IV-TR criteria for opiate dependence; have voluntary and informed consent. Exclusion criteria: suffer from serious chronic mental disease; history of suicide during last month; demonstrate withdrawal symptoms at the end of first two weeks of admission.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Improvement of cognitive performance. Timepoint: Baseline, Midterm, Final, follow- up(1,3,6 month). Method of measurement: Cognitive Assessment Battery.

Secondary

MeasureTime frame
Change in adiction treatment outcomes. Timepoint: At the end of intervention and follow- up (1,3,6 month). Method of measurement: Subjective reports, Urine tests.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactTara Rezapour

Translational Neuroscience Program, Institute for Cognitive Science Studies, Tehran, Iran

tara_rezapour@yahoo.com+98 21 5540 0034

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026